Cargando…
Suppression of the NF-κB cofactor Bcl3 inhibits mammary epithelial cell apoptosis and, in breast tumours, correlates with poor prognosis
Autores principales: | Wakefield, A, Piggott, L, Croston, D, Jiang, WG, Clarkson, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300703/ http://dx.doi.org/10.1186/bcr1884 |
Ejemplares similares
-
Suppression of the NF-κB co-factor, Bcl3, delays the metastatic progression of breast cancer
por: Wakefield, AM, et al.
Publicado: (2010) -
Stromal and epithelial TGF-β signaling in mammary tumorigenesis
por: Moses, HL, et al.
Publicado: (2005) -
UXT is a novel and essential cofactor in the NF-κB transcriptional enhanceosome
por: Sun, Shaogang, et al.
Publicado: (2007) -
ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-κB-dependent activation of Snail
por: Cichon, Magdalena A., et al.
Publicado: (2014) -
Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-κB-related signaling
por: Kuo, Sung-Hsin, et al.
Publicado: (2021)